Nanna Therapeutics
Aurelio Reyes is a seasoned researcher with extensive experience in the field of molecular genetics. Currently serving as a Senior Research Scientist at Astellas Engineered Small Molecules U.K. Ltd. since September 2020, Aurelio previously held positions as a Senior Scientist and Investigator Scientist at the Medical Research Council from October 2004 to June 2020. Aurelio's academic background includes a Doctor of Philosophy (Ph.D.) in Molecular Genetics from Universidad Complutense de Madrid, completed in 1995, as well as a Graduate degree in Biology/Biological Sciences from the same institution, earned in 1990.
Previous companies
This person is not in any offices
Nanna Therapeutics
Nanna Therapeutics is a drug discovery company addressing age-related diseases for which others are failing to provide effective treatments. These include mitochondrial, neurodegenerative, cardiovascular or metabolic, joint or tissue disease as well as cancer.Nanna Therapeutics are targeting fundamental cellular processes to create drugs to treatage-related diseases and improve longevity. Such drugs include those to combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. With a strong focus on mitochondria, the energy source in every cell, we can target the fundamental causes of many age-related diseases. Through this approach we can also address debilitating, life-limiting mitochondrial diseases for which there are currently few effective therapies.Nanna Therapeutics has developed a tightly integrated set of proprietary technologies that radically disrupt current methods of creating new medicines. This Totally Integrated Medicines Engine (TIME) has been devised to answer the needs of drug discovery and development scientists utilising the best in 21st century technologies of microfluidics, nanofabrication and artificial intelligence.